• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Insulet Corp (PODD)

Common Shares
Sell: $245.10|Buy: $253.70|Change: 1.02 (0.41%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

Address

100 Nagog Park
Acton
MA
USA
01720

Telephone

+1 978 6007717

Website

https://www.insulet.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Insulet Corp First Quarter Earnings Conference Call for 20262026-05-08T16:30:00
Insulet Corp First Quarter Earnings Results for 20262026-05-08T00:00:00
Insulet Corp Fourth Quarter Earnings Conference Call for 20252026-02-20T16:30:00
Insulet Corp Fourth Quarter Earnings Results for 20252026-02-20T00:00:00
Insulet Corp Annual Report for 20252026-02-20T00:00:00
Insulet Corp Third Quarter Earnings Conference Call for 20252025-11-07T16:30:00
Insulet Corp Third Quarter Earnings Results for 20252025-11-07T00:00:00
Insulet Corp Second Quarter Earnings Conference Call for 20252025-08-08T16:30:00
Insulet Corp Second Quarter Earnings Results for 20252025-08-08T00:00:00
Insulet Investor Day2025-06-05T10:00:00
Insulet Corp Annual General Meeting for 20252025-05-22T08:00:00
Insulet Corp First Quarter Earnings Conference Call for 20252025-05-08T16:30:00
Insulet Corp First Quarter Earnings Result for 20252025-05-08T00:00:00

Previous key dates

NameKey Date
Insulet Corp Annual General Meeting for 20252025-05-22T08:00:00
Insulet Corp First Quarter Earnings Conference Call for 20252025-05-08T16:30:00
Insulet Corp First Quarter Earnings Result for 20252025-05-08T00:00:00
Insulet Corp Annual Report for 20242025-02-21T00:00:00
Insulet Corp Fourth Quarter Earnings Conference Call for 20242025-02-20T16:30:00
Insulet Corp Fourth Quarter Earnings Result for 20242025-02-20T00:00:00
J.P. Morgan 43rd Annual Healthcare Conference2025-01-14T18:45:00
Nasdaq 51st Investor Conference2024-12-10T05:30:00
6th Annual Wolfe Research Healthcare Conference2024-11-20T12:00:00
Insulet Corp Third Quarter Earnings Conference Call for 20242024-11-07T16:30:00
Insulet Corp Third Quarter Earnings Result for 20242024-11-07T00:00:00
Baird 2024 Global Healthcare Conference2024-09-10T08:30:00
Morgan Stanley 22nd Annual Global Healthcare Conference2024-09-06T08:30:00
2024 Wells Fargo Healthcare Conference2024-09-04T09:30:00
Insulet Corp Second Quarter Earnings Conference Call for 20242024-08-08T16:30:00
Insulet Corp Second Quarter Earnings Result for 20242024-08-08T00:00:00
Jefferies Global Healthcare Conference2024-06-06T09:00:00
Insulet Corp Annual General Meeting for 20242024-05-22T08:00:00
Insulet Corp First Quarter Earnings Conference Call for 20242024-05-09T16:30:00
Insulet Corp First Quarter Earnings Result for 20242024-05-09T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.